Search for: "Robertson v. Ross"
Results 1 - 18
of 18
Sorted by Relevance
|
Sort by Date
16 Feb 2022, 6:01 am
" Robertson v. [read post]
30 Jul 2022, 6:01 am
Matt Perault detailed the shifting partisan fault lines in speech policy after Dobbs v. [read post]
13 Apr 2015, 12:56 pm
CORE v. [read post]
30 Dec 2022, 9:05 pm
Immigrants Living Under a Different Regulatory Scheme May 7, 2022 | Erica V. [read post]
17 Dec 2020, 12:08 pm
Maine 2002); Sullivan v. [read post]
17 Dec 2020, 12:08 pm
Maine 2002); Sullivan v. [read post]
13 Mar 2010, 9:46 pm
As Lambert J.A. says in Robertson at 388: …But the remarks made in the course of the reasons in Hawitt v. [read post]
6 Jun 2017, 3:57 am
In North Carolina v. [read post]
19 May 2017, 12:23 pm
Co. v. [read post]
5 Jun 2018, 2:59 pm
Supreme Court’s recent decision in Murphy v. [read post]
15 Dec 2020, 8:30 am
First, from the Marietta Daily Journal (Ross Williams), describing the basis for the $1.5 million verdict: Alpha OB/GYN … for years the target of sign-waving protesters, and was even the victim of arson in 2012. [read post]
8 Jun 2010, 7:34 pm
Co. v. [read post]
24 Dec 2023, 9:05 pm
FDA Advances Program for Real-World Evidence February 27, 2023 | Blair Bean Robertson, Thomas Jefferson University Hospitals FDA’s approach to evidence-based decision-making may not be addressed to the right people. [read post]
27 Mar 2019, 1:00 am
Panel – Getting Vaccines Right: Issues in Policy and Practice Moderator: Dorit Reiss, University of California Hastings College of the Law, Informed Consent to Vaccination: Theoretical, Legal, and Empirical Insights Ross Silverman, Indiana University, Professional Norms and Public Health Systems: Regulating Vaccination-Related Clinical Practices Litjen (L.J.) [read post]
1 Jun 2012, 7:02 am
Lone Wolf v. [read post]
1 Jun 2012, 7:02 am
Lone Wolf v. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
4 Mar 2010, 3:17 pm
The Agency’s response to any comments received will be available for public inspection at 1445 Ross Avenue, Dallas, Texas 75202. [read post]
